Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783689 · ClinicalTrials.gov registry record · NA
The SNAP Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain
A NA study, sponsored by SPR Therapeutics.
- Terminated
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03783689 is a NA study that was terminated before completion, run by SPR Therapeutics. The registered enrollment target is 38 participants.
The verdict
NCT03783689, a NA study, was terminated before completion, sponsored by SPR Therapeutics.
- TERMINATED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if pain can be relieved by delivering small amounts of electricity (called "electrical stimulation") to the nerves in an individual's amputated leg.This study will involve the use of a Peripheral Nerve Stimulation (PNS) System that is made by SPR Therapeutics (the sponsor of the study). The PNS System was cleared by the FDA for up to 60 days of use for the management of chronic pain, including extremity (leg) pain.
Interventions
- DEVICE SPRINT Peripheral Nerve Stimulation (PNS) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2022-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03783689
The ClinicalTrials.gov registry entry for NCT03783689 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SPR Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SPRINT Peripheral Nerve Stimulation (PNS) System is the first listed.
NCT03783689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03783689 about?
NCT03783689 is a clinical study titled "The SNAP Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Neuropathic Post-Amputation Pain". The purpose of this study is to determine if pain can be relieved by delivering small amounts of electricity (called "electrical stimulation") to the nerves in an individual's amputated leg.This study will involve the use of a Peripheral Nerve Stimulation (PNS) System that is made by SPR Therapeutic...
What is the current status of trial NCT03783689?
This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2018-12-18. Estimated completion is 2022-09-22.
What interventions are being tested in trial NCT03783689?
The interventions under investigation include: SPRINT Peripheral Nerve Stimulation (PNS) System (DEVICE).
Who is sponsoring clinical trial NCT03783689?
This trial is sponsored by SPR Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.